Pharmacist consultation. 7.1. The pharmacist will conduct a consultation. This will usually be face to face, but may be over the telephone if appropriate. The pharmacist must, using the CPCS IT system, collect information on the patient’s condition and make appropriate records, during the consultation. The pharmacist will assess the patient’s condition using a structured approach to respond to symptoms. Where the pharmacist undertakes a telephone consultation but is unable to collect all of the information they require from the patient or they feel that it is clinically appropriate to see the patient before making a decision on their condition, the pharmacist shall conduct a face-to-face consultation..
Pharmacist consultation. 6.1. The pharmacist will conduct a face-to-face consultation in the pharmacy consultation room and MUST use PharmOutcomes during that consultation. The PharmOutcomes platform MUST be used to collect any additional information from the patient that was not obtained during the telephone conversation with the patient. The pharmacist will assess the patient’s condition using a structured approach to responding to symptoms and using Summary Care Record where appropriate.
Pharmacist consultation. 7.1. The pharmacist will conduct a face-to-face consultation in the pharmacy consultation room. Chaperone or translation arrangements should be offered where appropriate to the needs of the patient. The DMIRS IT System must be used (via an electronic device) during that consultation so that the pharmacist can record any information relevant to the clinical consultation. Referral information provided by the GP practice may need to be manually inputted on the DMIRS IT System by the pharmacist. The pharmacist will assess the patient‟s symptoms using a structured approach and their own observations, using any locally held patient record and SCR where appropriate.
Pharmacist consultation. 6.1 The pharmacist will conduct a face-to-face consultation in the pharmacy consultation room and MUST use the locally commissioned IT provider template during that consultation. The the locally commissioned IT provider platform MUST be used to collect any additional information from the patient that was not obtained during the telephone conversation with the patient. The pharmacist will assess the patient’s condition using a structured approach to responding to symptoms and using Summary Care Record where appropriate.
Pharmacist consultation. The pharmacist will conduct a face-to-face consultation in the pharmacy consultation room and MUST use PharmOutcomes during that consultation. The PharmOutcomes platform MUST be used to collect any additional information from the patient that was not obtained during the telephone conversation with the patient. The pharmacist will assess the patient’s condition using a structured approach to responding to symptoms and using Summary Care Record where appropriate. The pharmacist will gain patient consent (tick box) to share the details of the consultation with the patients GP. Patients who do not consent to sharing details with their GP cannot access CPRS and will be transferred to usual care. The pharmacist will ensure that any relevant ‘Red Flags’ are recognised and responded to as part of the consultation process3. The red flags link will be included as a reminder within the IT platform so that pharmacists are able to click on the link and get the latest information directly from NICE Clinical Knowledge Summary whilst still with the patient during the consultation. If at this stage it is identified that the patient needs to be referred to access higher acuity services, then the procedure set out in section 8 should be followed. The pharmacist will identify any concurrent medication or medical conditions, which may affect the treatment of the patient. This can be done through access to Summary Care Record (SCR), where appropriate. The pharmacist will consider past medication supplied for the low acuity condition to assess appropriateness of any advice given. The pharmacist will provide self-care advice on the management of the condition. The pharmacist will provide a relevant information leaflet about the low acuity condition from a reputable source (an example of which would be NHS Choices or NICE Clinical Knowledge Summaries guides or from xxxxxxx.xx.xx) as required. See Annex A for the consultation process. Closing statement. For every consultation the pharmacist should give a standard closing statement to the patient: “IF YOUR SYMPTOMS DO NOT IMPROVE OR BECOME WORSE, THEN EITHER COME BACK TO SEE ME OR SEEK ADVICE FROM YOUR GP” Patients may wish to call NHS111 or 999 if the matter is urgent and the pharmacist or GP is not available. The pharmacist who carried out the consultation will complete some simple data collection questions and will request permission for participation in evaluation. (email/phone). If the patient refuses to take part in data colle...
